Profil
Kevin Moulder served as the Chief Development Officer at Tusk Therapeutics Ltd. from 2015 to 2018.
He then worked as the Chief Operating Officer at Polyprox Therapeutics Ltd. from 2018 to 2021.
In 2021, he became the Chief Scientific Officer at Medicenna Therapeutics Corp.
Dr. Moulder also held the position of Chief Scientific Officer at F-star Therapeutics Ltd. Dr. Moulder received a graduate and doctorate degree from the University of London.
Anciens postes connus de Kevin Moulder
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur Technique/Scientifique/R&D | 03/03/2022 |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases | Directeur des opérations | 01/02/2021 |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/09/2018 |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Directeur Technique/Scientifique/R&D | - |
Formation de Kevin Moulder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases | Health Technology |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Health Technology |
















